Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Akriti Seth

Senior Reporter

London, UK
As a correspondent for Channel NewsAsia, Singapore and for India Technology News, Akriti has covered a wide range of subject-matter including politics, economics and technology for a B2B audience. She has also gained experience working for Bloomberg TV India and Mid-Day Mumbai. Akriti is a graduate of the University of Mumbai and holds a masters from Mumbai's Xavier Institute of Communications. Most recently she has worked as a freelance journalist in London, where she is now based, having lived there for the past two years. She enjoys photography and blogging.
Set Alert for Articles By Akriti Seth

Latest From Akriti Seth

Strides Acquires 18 ANDAs From Pharmaceutics

Strides has acquired 18 ANDAs from Pharmaceutics International, as well as exclusive marketing rights to a levothyroxine sodium candidate. Through this agreement, the Indian company plans to expand its niche offerings.

Deals Generic Drugs

Teva’s Ellis Is New BBA Chair

Teva UK’s director of secondary care, Andrew Ellis, who has been a member of the British Biosimilars Association’s steering group, has now been appointed as its new chair.

Appointments Biosimilars

Generics Are Key To Address European Shortages

As Europe struggles to maintain an adequate and sustainable supply of affordable medicines, industry and regulators come together to discuss the key factors causing shortages and solutions to overcome them.

Regulation Europe

Smart Pharmacovigilance Is Critical For Europe

Simplification of pharmacovigilance processes is required not only in Europe but also globally, delegates to Medicines for Europe’s 2020 pharmacovigilance conference heard. Industry is also calling for greater transparency to better engage with the public on pharmacovigilance issues.

Europe Regulation

Amneal Aims To Expand Internationally

Amneal has laid out ambitious plans for 2020 to deliver value and volume growth, including by expanding internationally, augmenting organic growth through M&A and capitalizing on its pipeline of ANDAs and development projects. The firm will seek to build on its launch of 38 products in 2019 as well as benefiting from recent key appointments to its board.

Strategy United States

Abbott’s Established Unit Grows By A Tenth

Abbott’s Established Pharmaceuticals business saw double-digit organic growth in the fourth quarter of 2019 on the back of its “unique branded generic strategy in emerging markets,” particularly in Latin America and Asia.

Sales & Earnings Strategy
See All